1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Updated results from a multicenter study (LCMC3)
    Meeting Abstract

    Rusch, V.; Chaft, J.; Johnson, B.; Wistuba, I.; Kris, M.; Lee, J.; Bunn, P. Jr; Kwiatkowski, D.; Reckamp, K.; Finley, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive peripheral blood immunophenotyping and T-cell clonal analysis during neoadjuvant immunotherapy with atezolizumab in NSCLC
    Meeting Abstract

    Oezkan, F.; He, K.; Owen, D.; Pietrzak, M.; Kitzler, R.; Pearson, R.; Nicholas, A.; Bunn, P. Jr; Kris, M.; Kwiatkowski, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Neoantigen targeting and T cell reshaping in resectable NSCLC patients treated with neoadjuvant PD-1 blockade
    Meeting Abstract

    El Asmar, M.; Zhang, J.; Caushi, J.; Ji, Z.; Anagnostou, V.; Cottrell, T.; Chan, H. Y.; Suri, P.; Guo, H.; Marrone, K.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Responses and durability in NSCLC treated with pegilodecakin and anti-PD-1
    Meeting Abstract

    Garon, E.; Wong, D.; Schneider, J.; Aliumaily, R.; Korn, W.; Infante, J.; Patel, M.; Autio, K.; Papadopoulos, K.; Naing, A.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Immunotherapy for non-small cell lung cancers (NSCLC) with oncogenic driver mutations: New results from the global IMMUNOTARGET registry
    Meeting Abstract

    Gautschi, O.; Drilon, A.; Milia, J.; Lusque, A.; Mhanna, L.; Li, B.; Sabari, J.; Cortot, A.; Besse, B.; Mezquita, L.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes in NSCLC patients treated with first-line pembrolizumab and a PD-L1 TPS of 50-74% vs 75-100% or 50-89% vs 90-100%
    Meeting Abstract

    Jomenez Alguilar, E.; Gainor, J.; Kravets, S.; Khosrowjerdi, S.; Lydon, C.; Adeni, A.; Subegdjo, S.; Rizvi, H.; Hellmann, M.; Awad, M.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical activity of LOXO-292, a highly selective RET inhibitor, in patients with RET fusion+ non-small cell lung cancer
    Meeting Abstract

    Oxnard, G.; Subbiah, V.; Park, K.; Bauer, T.; Wirth, L.; Velcheti, V.; Shah, M.; Besse, B.; Boni, V.; Reckamp, K.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Updated antitumor activity of crizotinib in patients with MET exon 14-altered advanced non-small cell lung cancer
    Meeting Abstract

    Drilon, A.; Clark, J.; Weiss, J.; Ou, S.; Camidge, D. R.; Solomon, B.; Otterson, G.; Villaruz, L.; Riely, G.; Heist, R.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy/safety of entinostat (ENT) and pembrolizumab (PEMBRO) in NSCLC patients previously treated with anti-PD-(L) 1 therapy
    Meeting Abstract

    Hellmann, M.; Jänne, P.; Opyrchal, M.; Hafez, N.; Raez, L.; Gabrilovich, D.; Wang, F.; Ordentlich, P.; Brouwer, S.; Sankoh, S.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase II data for the MET inhibitor tepotinib in patients with advanced NSCLC and MET exon 14-skipping mutations
    Meeting Abstract

    Felip, E.; Sakai, H.; Patel, J.; Horn, L.; Veillon, R.; Griesinger, F.; Bruns, R.; Scheele, J.; Paik, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save